Loop diuretics in chronic heart failure: how to manage congestion?

Heart Fail Rev. 2019 Jan;24(1):17-30. doi: 10.1007/s10741-018-9735-7.

Abstract

Loop diuretics remain the cornerstone of congestion management in contemporary chronic heart failure care. However, their use is not supported by high quality data, and there is doubt about the safety in the outpatient heart failure setting. Still, congestion is related to a worse outcome, and there is general consensus among experts that congestion should not be tolerated in heart failure patients. Recommendations in international guidelines, regarding decongestion strategies in chronic heart failure, are limited. Thus, there is an emerging need for clinical decision-making support about the best strategy for using loop diuretics and decongestion in the chronic setting. The present review provides a comprehensive overview over the evidence of chronic loop diuretic use. Strategies for the assessment of congestion in the outpatient setting and decongestion algorithm are provided to assist health care specialists in delivering high-quality heart failure care.

Keywords: Chronic heart failure; Decongestion; Diuretic resistance; Diuretic therapy; Loop diuretic; Volume overload.

Publication types

  • Review

MeSH terms

  • Aged
  • Animals
  • Chronic Disease
  • Consensus
  • Disease Models, Animal
  • Heart Failure / drug therapy*
  • Humans
  • Hyperemia / diagnosis*
  • Hyperemia / drug therapy*
  • Middle Aged
  • Rats
  • Sodium Potassium Chloride Symporter Inhibitors / adverse effects*
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use*
  • Treatment Outcome

Substances

  • Sodium Potassium Chloride Symporter Inhibitors